ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,872,278 | -28.8% | 407,017 | 0.0% | 5.10% | -45.7% |
| Q2 2023 | $2,629,330 | -14.3% | 407,017 | 0.0% | 9.39% | -34.0% |
| Q1 2023 | $3,068,908 | -25.6% | 407,017 | 0.0% | 14.23% | -31.1% |
| Q4 2022 | $4,123,082 | +2.4% | 407,017 | 0.0% | 20.66% | +78.9% |
| Q3 2022 | $4,025,000 | -7.1% | 407,017 | 0.0% | 11.55% | -8.8% |
| Q2 2022 | $4,334,000 | +9.2% | 407,017 | 0.0% | 12.66% | +182.8% |
| Q1 2022 | $3,968,000 | -31.8% | 407,017 | 0.0% | 4.48% | +36.6% |
| Q4 2021 | $5,820,000 | – | 407,017 | – | 3.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 7,305,761 | $104,472,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $53,961,000 | 89.75% |
| Gruss & Co., LLC | 426,966 | $6,106,000 | 16.39% |
| SB Management Ltd | 9,817,190 | $140,386,000 | 13.88% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $58,703,000 | 5.51% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $45,346,000 | 4.36% |
| Intellectus Partners, LLC | 1,192,379 | $17,051,000 | 4.35% |
| Founders Fund Growth Management, LLC | 407,017 | $5,820,000 | 3.28% |
| ArchPoint Investors | 461,289 | $6,596,000 | 1.96% |
| Belmont Capital, LLC | 150,000 | $2,145,000 | 1.68% |